DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
_256_384.jpg){kind=logo}
Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
The domestic business has registered a single-digit growth on the huge base of last year and this was driven by robust demand across established therapies and brands
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
